The univariate analysis highlighted that metastasized disease, AJCC stage, adjuvant CT, cycles of adjuvant CT, surgery type, lymphovascular invasion, perineural invasion, preoperative CEA levels, and histologic type were significantly predictive for longer survival (Table 4), whereas gender, tumor size, and T stage were insignificant variables. This evidence concerns the gene CEACAM5 and neoplasm.